Vaxart, Inc. - Common Stock Price Today
![image quote](https://financialmodelingprep.com/image-stock/VXRT.png)
Vaxart, Inc. - Common Stock
VXRT
Healthcare
$187.77M
๐ฐ
Market Cap
0
๐ธ
Price to Earnings
$-0.6
๐
EPS
+0
๐ณ
ESG
Consensus Recommendations
Buy Consensus
Buy |
5 |
Strong Buy |
3 |
Hold |
1 |
Sell |
0 |
Strong Sell |
0 |
VXRT Price Forecast Target
1.1 ๐ 8.0 +641%
VXRT EPS Forecast
-0.6 ๐ -0.4 +-32%
Financials
Profit Margin
0 %
Revenue Growth
14650.0 %
Dividend
$ 0
Held Percent
1.0% - Insiders
18.1% - Institutions
80.9% - Public
Major Fund Holders
-
๐ฐ Vanguard Group Inc $7.6M
-
๐ฐ Geode Capital Management, LLC $2.1M
-
๐ฐ Blackrock Inc. $1.9M
-
๐ฐ Citadel Advisors Llc $538,939.0
-
๐ฐ Gsa Capital Partners Llp $527,575.0
Stock Ideas
Michael Burry Portfolio
Michael Burry, the renowned value investor and founder of Scion Asset Management, gained limited recognition until his story was documented in Michael Lewis' bestseller 'The Big Short.' Despite predicting the subprime mortgage crisis, Scion's AUM feโฆCharlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and โฆSeth Klarman Portfolio
Seth Klarman's investment prowess is exemplified by his exceptional track record. Since the inception of his fund until 2008, he achieved an impressive compound return-on-investment of 20%. This remarkable achievement showcases his astute investmentโฆLarry Robbins Portfolio
Larry Robbins is a successful hedge fund manager who founded Glenview Capital in 2001 after working as a trader at Omega Advisors. His portfolio strategy has led to impressive returns, with Glenview Capital returning 301% after fees and expenses betโฆ๐ฎFAQ
Some Frequently Asked Questions.
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The Vaxart, Inc. - Common Stock industry is Biotechnology
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The Vaxart, Inc. - Common Stock sector is Healthcare
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The Vaxart, Inc. - Common Stock forecasted predicted Price to Earnings PE ratio is -2.8
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The Vaxart, Inc. - Common Stock Price to Earnings PE ratio is 0
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The Market Capitalization of Vaxart, Inc. - Common Stock is $187.77M
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
There are total of 156957112 float shares with 18.1% held by Institutions and 1.0% held by insiders
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The MVaxart, Inc. - Common Stock forecasted Earnings per Share EPS is $-0.4
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The Vaxart, Inc. - Common Stock Earnings per Share EPS is -0.6
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The Vaxart, Inc. - Common Stock company has $0 gross profits with 0 profit margins
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The Vaxart, Inc. - Common Stock Earnings Growth is 0% with 0% quarterly earnings growth
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The Vaxart, Inc. - Common Stock Revenue is $7379000 with 146.5 revenue growth
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The price target for Vaxart, Inc. - Common Stock stock is $8.0 for the high target and $2.0 for the low target
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The consensus analyst recommendations for Vaxart, Inc. - Common Stock is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The consensus analyst recommendations for Vaxart, Inc. - Common Stock is Buy, with the following breakdown:
- Buy: 5
- Strong Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The Beta of Vaxart, Inc. - Common Stock is 0.6
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The dividend of Vaxart, Inc. - Common Stock is $0
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The dividend yield of Vaxart, Inc. - Common Stock is 0%
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The biggest institutional and mutual fund holders of Vaxart, Inc. - Common Stock stock are
- Vanguard Group Inc
- Geode Capital Management, LLC
- Blackrock Inc.
- Citadel Advisors Llc
![rocket money aiovel](/static/assets/img/illustrations/chat.png)
The Vaxart, Inc. - Common Stock ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0